USFDA concludes surveillance inspection at Zydus group’s API unit in Gujarat

28 Apr 2025 Evaluate

United States Food and Drug Administration (USFDA) has concluded surveillance inspection at Zydus group’s API Unit, located at Dabhasa in Gujarat. The inspection was conducted from April 21 to 25, 2025. The inspection concluded with 6 observations and none of them were related to Data Integrity. The company is confident to address the observations expeditiously. 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

911.50 -5.95 (-0.65%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×